MB

MPM BioImpact Portfolio holdings

AUM $577M
1-Year Est. Return 8.33%
This Quarter Est. Return
1 Year Est. Return
+8.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$704M
AUM Growth
+$37.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
54
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$18M
3
+$15.6M
4
CNTX icon
Context Therapeutics
CNTX
+$15.4M
5
REPL icon
Replimune Group
REPL
+$11.5M

Top Sells

1
+$15.6M
2
+$15.4M
3
+$10.4M
4
VKTX icon
Viking Therapeutics
VKTX
+$7.66M
5
NTLA icon
Intellia Therapeutics
NTLA
+$5.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$93.2M 13.23%
7,648,268
2
$31.5M 4.48%
617,035
+91,190
3
$28.8M 4.09%
1,079,316
+162,150
4
$26.9M 3.82%
389,611
-225,780
5
$25.4M 3.61%
160,626
-16,473
6
$24.4M 3.46%
589,579
+96,856
7
$22M 3.12%
346,401
+34,640
8
$21.1M 3%
236,213
+86,031
9
$21M 2.97%
+800,000
10
$20.4M 2.9%
702,981
+14,006
11
$19.8M 2.81%
2,673,905
+267,191
12
$19.6M 2.79%
434,767
+345,052
13
$18.4M 2.62%
1,489,237
+864,766
14
$18M 2.55%
+416,144
15
$17.1M 2.42%
315,230
-33,833
16
$17M 2.41%
2,912,550
+231,954
17
$16.5M 2.34%
391,018
+61,285
18
$15.4M 2.19%
+14,705,882
19
$13.8M 1.96%
452,739
-46,431
20
$13.7M 1.95%
313,817
+22,426
21
$13.4M 1.9%
1,745,943
22
$12.9M 1.83%
721,139
+91,716
23
$12.8M 1.82%
1,020,559
-45,814
24
$12.8M 1.82%
460,617
+68,073
25
$12.8M 1.81%
3,094,896
+1,556,379
1
2 3